What is the purpose of administering antiangiogenic agents?

What is the purpose of administering antiangiogenic agents?

• A. To promote blood vessel formation
• B. To support immune responses
• C. To prevent new blood vessel growth
• D. To enhance chemotherapy effects

Answer: (C)

The purpose of administering antiangiogenic agents is to prevent new blood vessel growth. These medications work by targeting the mechanisms that promote angiogenesis, which is the process through which new blood vessels form from existing ones. Tumors often require a sufficient blood supply to grow and metastasize, and by inhibiting angiogenesis, antiangiogenic agents can effectively starve the tumor of the nutrients and oxygen it needs to thrive. This approach can help to slow down or even shrink tumors, making it a crucial strategy in cancer treatment. In contrast, promoting blood vessel formation is counterproductive in the context of cancer therapy, as it would support tumor growth rather than inhibit it. Supporting immune responses relates to immunotherapy, which focuses on enhancing the body's immune system to fight cancer, rather than specifically targeting angiogenesis. While there is an interplay between some chemotherapy treatments and antiangiogenic agents, the primary role of antiangiogenic agents is not to enhance chemotherapy effects directly but to disrupt the blood supply that is vital for tumor survival.

The purpose of administering antiangiogenic agents is to prevent new blood vessel growth. These medications work by targeting the mechanisms that promote angiogenesis, which is the process through which new blood vessels form from existing ones. Tumors often require a sufficient blood supply to grow and metastasize, and by inhibiting angiogenesis, antiangiogenic agents can effectively starve the tumor of the nutrients and oxygen it needs to thrive. This approach can help to slow down or even shrink tumors, making it a crucial strategy in cancer treatment.

In contrast, promoting blood vessel formation is counterproductive in the context of cancer therapy, as it would support tumor growth rather than inhibit it. Supporting immune responses relates to immunotherapy, which focuses on enhancing the body's immune system to fight cancer, rather than specifically targeting angiogenesis. While there is an interplay between some chemotherapy treatments and antiangiogenic agents, the primary role of antiangiogenic agents is not to enhance chemotherapy effects directly but to disrupt the blood supply that is vital for tumor survival.